Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05404945
Title Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Virginia
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Rutgers Cancer Institute of New Jersey RECRUITING New Brunswick New Jersey 08902-2681 United States Details
University of Pennsylvania NOT_YET_RECRUITING Philadelphia Pennsylvania 19104 United States Details
University of Virginia RECRUITING Charlottesville Virginia 22911 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field